首页> 外文OA文献 >Hot-melt co-extrusion as manufacturing technique for multilayer oral dosage forms
【2h】

Hot-melt co-extrusion as manufacturing technique for multilayer oral dosage forms

机译:热熔共挤出作为多层口服剂型的制造技术

摘要

Co-extrusion implies the simultaneous hot-melt extrusion of two or more materials through the same die, creating a multilayered extrudate. This innovative continuous production technology offers numerous advantages over traditional pharmaceutical processing techniques. Moreover co-extrusion provides great potential for the production of fixed-dose combination products which are gaining importance in pharmaceutical industry. Except from an implant (Implanon®) and a vaginal ring (Nuvaring®), there are no co-extruded dosage forms on the market so far. The aim of this work was to evaluate the potential of hot-melt coextrusion for the production of multilayer (core/coat) oral dosage forms. Possible applications are pointed out and polymers which can be combined in co-extruded dosage forms are selected.In the introduction, the equipment and downstream solutions for processing coextrudates into drug products are reviewed. Requirements and challenges in material selection, considering melt viscosity and multilayer adhesion are pointed out. Examples of medical and pharmaceutical applications are presented and some recent findings considering the production of oral drug delivery systems are summarized. Chapter 1 gives a brief overview of the polymer characteristics relevant for hot-melt co-extrusion (including solubility, hygroscopicity, toxicity, thermal stability, melt viscosity and extrudability). In chapter 2, fixed-dose combination dosage forms are developed by means of hot-melt coextrusion, the core providing sustained drug release and the coat immediate drug release. In chapter 3, hot-melt co-extrusion is assessed for the development of multilayered dosage forms characterized by a dual release profile of the same drug. In chapter 4, fixed-dose combination dosage forms are developed characterized by immediate release for both layers, the layers containing different drugs with different water-solubility. Chapter 5 is a critical evaluation of the co-extrusion process. This chapter questions if hot-melt co-extrusion offers an added value over hot-melt extrusion.
机译:共挤出意味着通过同一模具同时将两种或多种材料热熔挤出,从而形成多层挤出物。与传统的药物加工技术相比,这种创新的连续生产技术具有许多优势。此外,共挤出为固定剂量组合产品的生产提供了巨大潜力,而固定剂量组合产品在制药工业中变得越来越重要。除了植入物(Implanon®)和阴道环(Nuvaring®)以外,到目前为止市场上还没有共挤出剂型。这项工作的目的是评估热熔共挤出生产多层(芯/衣)口服剂型的潜力。指出了可能的应用,并选择了可以以共挤出剂型组合的聚合物。在引言中,回顾了将共挤出物加工成药品的设备和下游解决方案。指出了材料选择的要求和挑战,同时考虑了熔体粘度和多层粘附性。介绍了医疗和制药应用的示例,并总结了考虑口服药物输送系统生产的一些最新发现。第1章简要概述了与热熔共挤出相关的聚合物特性(包括溶解度,吸湿性,毒性,热稳定性,熔体粘度和可挤出性)。在第2章中,通过热熔共挤出技术开发了固定剂量组合剂型,其中核心提供了持续的药物释放和衣壳即刻的药物释放。在第3章中,对热熔共挤出进行了评估,以开发以相同药物的双重释放特征为特征的多层剂型。在第4章中,开发了固定剂量的组合剂型,其特征在于两层立即释放,其中各层包含具有不同水溶性的不同药物。第5章是对共挤出过程的重要评估。本章质疑热熔共挤出是否比热熔挤出更具附加值。

著录项

  • 作者

    Dierickx Lien;

  • 作者单位
  • 年度 2014
  • 总页数
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号